Effect of temozolomide on survival in elderly patients with glioblastoma and impaired performance status: a propensity score-matching analysis

References

• OstromQTGittlemanHLiaoPCBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011Neurooncology201416163
   PubMed Web of Science ®Google Scholar
• ChakrabartiICockburnMCozenWWangYPPreston-MartinSA population-based description of glioblastoma multiforme in Los Angeles County, 1974–1999Cancer20051042798280616288487
   PubMed Web of Science ®Google Scholar
• StuppRBradaMvan den BentMJTonnJCPentheroudakisGESMO Guidelines Working GroupHigh-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol20142593101
   Web of Science ®Google Scholar
• MalmstromAGrønbergBHStuppRGlioblastoma (GBM) in elderly patients: a randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ)J Clin Oncol201028Suppl abstr LBA2002180s
   Google Scholar
• StuppRMasonWPvan den BentMJEuropean Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy GroupsNational Cancer Institute of Canada Clinical Trials GroupRadiotherapy plus concomitant and adjuvant temozolomide for glio-blastomaN Engl J Med20053521098799615758009
   PubMed Web of Science ®Google Scholar
• Gállego Pérez-LarrayaJDucrayFChinotOTemozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trialJ Clin Oncol201129223050305521709196
   PubMed Web of Science ®Google Scholar
• MalmströmAGrønbergBHMarosiCTemozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trialLancet Oncol201213991692622877848
   PubMed Web of Science ®Google Scholar
• CharlsonMSzatrowskiTPPetersonJGoldJValidation of a combined comorbidity indexJ Clin Epidemiol19944711124512517722560
   PubMed Web of Science ®Google Scholar
• EstellerMHamiltonSRBurgerPCBaylinSBHermanJGInactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasiaCancer Res199959479379710029064
   PubMed Web of Science ®Google Scholar
• MinnitiGScaringiCLanzettaGStandard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysisInt J Radiat Oncol Biol Phys201591110911525442339
   PubMedGoogle Scholar
• GrayRJA class of k-sample tests for comparing the cumulative incidence of a competing riskAnn Stat19881611411154
   Web of Science ®Google Scholar
• CounsellCEGrantRIncidence studies of primary and secondary intracranial tumors: a systematic review of their methodology and resultsJ Neurooncol19983732412509524082
   PubMedGoogle Scholar
• ArvoldNDReardonDATreatment options and outcomes for glioblastoma in the elderly patientClin Interv Aging2014935736724591820
   PubMed Web of Science ®Google Scholar
• KarranABlakePChanDPropensity score analysis of oesopha-geal cancer treatment with surgery or definitive chemoradiotherapyBr J Surg2014101550251024615406
   PubMed Web of Science ®Google Scholar
• CorryJSmithJGWirthAQuongGLiewKHPrimary central nervous system lymphoma: age and performance status are more important than treatment modalityInt J Radiat Oncol Biol Phys1998416156209635710
   PubMed Web of Science ®Google Scholar
• GlantzMChamberlainMLiuQLitofskyNSRechtLDTemozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomasCancer20039792262226612712481
   PubMed Web of Science ®Google Scholar
• BabuRKomisarowJMAgarwalVJGlioblastoma in the elderly: the effect of aggressive and modern therapies on survivalJ Neurosurg20161244998100726452121
   PubMed Web of Science ®Google Scholar
• WickWPlattenMMeisnerCNOA-08 Study Group of Neuro-oncologyWorking Group (NOA) of German Cancer SocietyTemozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialLancet Oncol201213770771522578793
   PubMed Web of Science ®Google Scholar
• YinAACaiSDongYAmeta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patientsJ Neurooncol2014116231532424178440
   PubMedGoogle Scholar
• ReifenbergerGHentschelBFelsbergJGerman Glioma NetworkPredictive impact of MGMT promoter methylation in glioblastoma of the elderlyInt J Cancer20121311342135022139906
   PubMed Web of Science ®Google Scholar
• Reyes-BoteroGHonnoratJChinotOLTemozolomide plus bevacizumab in elderly patients with newly diagnosed glioblastoma and poor performance status: an Anocef Phase II trialJ Clin Oncol20133115 Suppl2020
   Google Scholar
• HegiMEDiserensACGodardSClinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomideClin Cancer Res20041061871187415041700
   PubMed Web of Science ®Google Scholar
• EstellerMGarcia-FoncillasJAndionEInactivation of the DNA repair gene MGMT and the clinical response of gliomas to alkylating agentsN Engl J Med2000343191350135411070098
   PubMed Web of Science ®Google Scholar
• HegiMEDiserensACGorliaTMGMT gene silencing and benefit from temozolomide in glioblastomaN Engl J Med200535210997100315758010
   PubMed Web of Science ®Google Scholar
• JordanJTGerstnerERBatchelorTTCahillDPPlotkinSRGlioblastoma care in the elderlyCancer2016122218919726618888
   PubMedGoogle Scholar
• KuhntDBeckerAGanslandtOBauerMBuchfelderMNimskyCCorrelation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidanceNeuro Oncol201113121339134821914639
   PubMed Web of Science ®Google Scholar
• LacroixMAbi-SaidDFourneyDRA multivariable analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survivalJ Neurosurg200195190198
   PubMed Web of Science ®Google Scholar
• StummerWReulenHJMeinelTExtent of resection and survival in glioblastoma multiforme: identification of and adjustment for biasNeurosurgery20086256457618425006
   PubMed Web of Science ®Google Scholar
• GzellCWheelerHGuoLKastelanMBackMElderly patients aged 65–75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomideJ Neurooncol201411918719624830984
   PubMed Web of Science ®Google Scholar
• HoffermannMBruckmannLKariem MahdyAAsslaberMPayerFvon CampeGTreatment results and outcome in elderly patients with glioblastoma multiforme – a retrospective single institution analysisClin Neurol Neurosurg2015128606925462098
   PubMedGoogle Scholar